Related Experiment Videos
Evaluation of autogenous tissue breast reconstruction using MRI
C Y Ahn1, K Narayanan, D P Gorczyca
1UCLA Medical Center, Division of Plastic Surgery 90024-1665.
Plastic and Reconstructive Surgery
|January 1, 1995
Summary
Magnetic resonance imaging (MRI) effectively visualizes autogenous tissue flaps used in breast reconstruction after mastectomy. This technique aids in monitoring cancer recurrence by clearly showing flap anatomy and tissue composition.
Area of Science:
- Medical Imaging
- Oncology
- Plastic Surgery
Background:
- Silicone breast implant controversies have led to increased use of autogenous tissue for breast reconstruction.
- Post-mastectomy autogenous tissue reconstruction requires surveillance for recurrent or new cancer.
- Magnetic resonance imaging (MRI) offers high resolution for soft tissue delineation.
Purpose of the Study:
- To evaluate the utility of MRI in imaging various autologous tissue donor sites for breast reconstruction.
- To demonstrate the MRI appearance of different flap types and their tissue components.
- To highlight the importance of MRI in the surveillance of breast cancer patients undergoing reconstruction.
Main Methods:
- MRI scans were performed on patients who underwent autogenous tissue breast reconstruction.
- Included flap types: fleur-de-lis, TRAM, gluteal, and tensor fasciae latae.
- Ten clinical cases were analyzed, illustrating flap anatomy and tissue composition (skin, fat, muscle).
Main Results:
- MRI successfully visualized the anatomic basis and tissue components of different autologous flaps.
- The MRI appearance of skin, fat, and muscle within the flaps was demonstrated.
- The interface between the flap, breast, and chest wall was clearly depicted on MRI scans.
Conclusions:
- MRI is a valuable tool for imaging autologous tissue flaps used in breast reconstruction.
- Understanding the MRI characteristics of these flaps is crucial for patient surveillance.
- Accurate interpretation of MRI is critical for the follow-up of breast cancer patients with autogenous tissue reconstruction.